
About Enko Chem
Enko Chem is a company based in Boston (United States) founded in 2017 by Jacqueline Heard. It develops and supplies agriculture crop inputs. Enko Chem has raised $124.7 million across 4 funding rounds from investors including Gates Foundation, Nufarm and Anterra Capital. The company has 32 employees. Enko Chem has completed 1 acquisition, including X-Chem. Its chief executive, as recorded, is Jacqueline Heard. Enko Chem offers products and services including Agricultural Technology and Grain Marketing. Its legal entity is Enko, Inc.
Company details
Enko Chem was founded in 2017 and is headquartered in Boston, United States. Agriculture crop inputs are developed and supplied, with a focus on insecticides, herbicides, and fungicides. These products are manufactured at a facility in Boston to address weeds, insects, and diseases in crops. Operations emphasize yield support and efficiency in the agricultural sector.
- Headquarters Boston, United States
- Employees 32
- Founders Jacqueline Heard
- Emailβ’β’β’β’β’β’β’β’
- Website enkochem.com
- Legal Name Enko, Inc
- Total Equity Funding$124.7M (USD)
in 4 rounds
- Latest Funding Round$70M (USD), Series C
Jul 2022
- InvestorsGates Foundation
& 12 more
- Employee Count32
- Investments & Acquisitions
Products & Services of Enko Chem
Enko Chem offers a comprehensive portfolio of products and services, including Agricultural Technology and Grain Marketing.
Products related to crop management and farming are handled by the company
Services for promoting and distributing grains are offered
Funding Insights of Enko Chem
Enko Chem has successfully raised a total of $124.7M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $70 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $124.7M
- Total Rounds 4
- Last Round Series C β $70M
- First Round $7.5M
(Jul 2018)
- Investors Count 13
All 4 funding rounds of Enko Chem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $70M | Series C | β | Nufarm | |
| Jun 2021 | $2.2M | Series B | β | β | |
| Jun 2020 | $45M | Series B | β | Gates Foundation | |
| Jul 2018 | $7.5M | Series A | β | β | β |
13 investors in total: 12 institutional and 1 angel.
Investors in Enko Chem
Enko Chem has secured backing from 13 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Gates Foundation, Nufarm and Anterra Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech focused growth stage VC firm investing in Europe & North America | 2012 | anterracapital.com | Amsterdam, Netherlands | |
Venture capital investment and global platform support for startups. | 2008 | eightroads.com | London, United Kingdom | |
| finistere.com | ||||
Investment and advisory services are provided for life sciences. | 2017 | novalislifesciences.com | Portsmouth, USA | |
Venture capital investments are focused on FoodTech and AgTech sectors. | germin8ventures.com | Chicago, USA | ||
Endeavor8 is focused on backing entrepreneurs and scientists in novel technology for food and agriculture. | endeavor8.com | San Francisco, United States | ||
Venture capital investing and portfolio management services for accredited investors. | av.vc | |||
Investment arm of Rabobank, focusing on equity capital provision. | raboinvestments.com | Utrecht, Netherlands | ||
| toventuresfood.tcc.mode | ||||
Venture capital services for biotech, IT, and innovative sectors in Connecticut. | ctinnovations.com |
Investor details for Enko Chem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Enko Chem
10 people are tracked at Enko Chem (5 in leadership, 5 in team); the tracked headcount is 32.
| Name | Role | Group |
|---|---|---|
Jacqueline Heard | Founder & CEO | Leadership |
Peter Stchur | Senior Vice President, Portfolio At Enko Chem, Inc. | Leadership |
Karin Whiting Burgess | Communications Director | Leadership |
Tim Panosian | Senior Director - Enkompass Platform | Leadership |
Sonny P. Smith | Vice President Finance | Leadership |
Daniel Pearson | Intellectual Property Manager | Team |
Stephanie Liva | General Counsel | Team |
Sarah Grieco | Office Manager | Team |
Paolo Castiglioni | Field Biology Lead | Team |
Brittany Baisch, PhD, DABT | Regulatory Toxicology Lead | Team |
Complete people profiles for Enko Chem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enko Chem
Enko Chem has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include X-Chem.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Small molecule drug discovery platform is provided to researchers. | x-chemrx.com | Waltham, United States | 2009 | Jun 2022 | β’β’β’β’ |
Complete acquisition details for Enko Chem
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Enko Chem
4 dated milestones of Enko Chem across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Enko Chem is founded.
- Funding First funding round of $7.5M.
- Acquisition Acquires X-Chem.
- Funding Latest funding round, Series C, of $70.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Enko Chem
Enko Chem was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Enko Chem is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Jacqueline Heard is the CEO of Enko Chem, as recorded in our data. They have also founded this company.
Enko Chem is a funded company, having raised a total of $124.7M across 4 funding rounds to date. The company's 1st funding round was a Series A of $7.5M, raised on Jul 2018.
Enko Chem has 32 employees.
Enko Chem was founded in 2017 and is headquartered in Boston, United States. Agriculture crop inputs are developed and supplied, with a focus on insecticides, herbicides, and fungicides. These products are manufactured at a facility in Boston to address weeds, insects, and diseases in crops. Operations emphasize yield support and efficiency in the agricultural sector.
Enko Chem offers Agricultural Technology and Grain Marketing.
Enko Chem has made 1 acquisition, including X-Chem.
Enko Chem has 13 investors. Key investors include Gates Foundation, Nufarm, Anterra Capital, Eight Roads Ventures, and Finistere Ventures.
Enko Chem operates through Enko, Inc.